Skip to content

Drug interactions

Lorlatinib + Palovarotene

Severity: Moderate

Lorlatinib and Palovarotene: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Palovarotene is cleared mainly by CYP3A4, and lorlatinib can induce this enzyme. Lower palovarotene exposure may reduce its efficacy in limiting heterotopic ossification.

What this interaction means in plain words

Lorlatinib and Palovarotene can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lorlatinib belongs to Oncology; Palovarotene belongs to Miscellaneous.

Evidence level: Low

Why it happens

Lorlatinib induces CYP3A4, accelerating palovarotene metabolism.

What to do

Avoid the combination where possible; if used together, monitor for reduced palovarotene efficacy and review therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lorlatinib and Palovarotene, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lorlatinib with Palovarotene?

MediHelp rates the interaction as moderate. Lorlatinib and Palovarotene can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Palovarotene is cleared mainly by CYP3A4, and lorlatinib can induce this enzyme. Lower palovarotene exposure may reduce its efficacy in limiting heterotopic ossification.

How serious is the interaction between Lorlatinib and Palovarotene?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible; if used together, monitor for reduced palovarotene efficacy and review therapy.

What other medicines interact with Lorlatinib?

MediHelp also lists interactions of Lorlatinib with, for example, Amobarbital, Apalutamide, Butabarbital. The full list is on the Lorlatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in